CRA Study Guide 2026
Everything you need to pass the CRA exam in one place: the exam format, every topic to study, real practice questions with explanations, flashcards, and full-length practice tests. Free, no sign-up needed.
📋 CRA Exam Format at a Glance
📚 CRA Topics to Study (21)
✍️ Sample CRA Questions & Answers
1. What is the primary purpose of a kit number or bottle number on investigational product in a blinded study?
Kit and bottle numbers uniquely identify each unit of investigational product, enabling full accountability and tracking without revealing the treatment assignment in blinded studies.
2. A CRA professional encounters an unfamiliar situation while performing quantitative & qualitative methods duties. What is the most appropriate first action?
When facing unfamiliar situations in quantitative & qualitative methods, the most appropriate action is to consult relevant standards, guidelines, or a qualified supervisor. This ensures safety, accuracy, and compliance while building professional knowledge.
3. What is the purpose of data triangulation?
Data triangulation involves using several different data sources, methods, or investigators to study the same phenomenon. This approach strengthens the validity and reliability of research findings by providing multiple perspectives and cross-verifying conclusions, increasing confidence in the overall results.
4. A CRA professional encounters an unfamiliar situation while performing systematic review & meta-analysis duties. What is the most appropriate first action?
When facing unfamiliar situations in systematic review & meta-analysis, the most appropriate action is to consult relevant standards, guidelines, or a qualified supervisor. This ensures safety, accuracy, and compliance while building professional knowledge.
5. Which of the following best describes the process of 'signal detection' in clinical trial safety monitoring?
Signal detection involves systematically reviewing aggregate adverse event data to identify new, unexpected, or changing safety patterns that may require further investigation.
6. An investigator in a US clinical trial observes a new, unexpected serious adverse event that is possibly related to the study drug. To whom should this be reported first?
Investigators must report SAEs to the sponsor within the timeframe specified in the protocol (typically 24–48 hours), and the sponsor then fulfills FDA reporting obligations.